Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Novartis Pharmaceuticals
Age
33–96
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Recent primary surgery for breast cancer
Early stage breast cancer
Postmenopausal
Hormone receptor positive
Positive lymph node involvement
You may not be if
Metastatic disease
Presence of contralateral breast cancer including DCIS
Progression
Clareo Health | Comparison Trial of Letrozole to Anastrozole in the Adjuvant Treatment of Postmenopausal Women With Hormone Receptor and Node Positive Breast Cancer
